BNP Paribas Financial Markets
LPCN icon

BNP Paribas Financial Markets’s Lipocine LPCN Stock Holding History

BNP Paribas Financial Markets’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Hold
0
– -$11 – 4465
2019
Q3 		– Hold
0
– – – 4485
2019
Q2 		– Hold
0
– – – 4514
2019
Q1 		– Hold
0
– – – 4255
2018
Q4 		– Hold
0
– – – 4304
2018
Q3 		– Hold
0
– – – 4423
2018
Q2 		– Hold
0
– – – 4401
2018
Q1 		– Hold
0
– – – 4205
2017
Q4 		– Hold
0
– – – 4188
2017
Q3 		– Hold
0
– – – 4200
2017
Q2 		– Sell
-12
Closed -$783 – 4221
2017
Q1 		$819 Sell
12
-46
-79% -$2.98K ﹤0.01% 3746
2016
Q4 		$3.64K Sell
58
-8
-12% -$506 ﹤0.01% 3805
2016
Q3 		$5.02K Buy
66
+27
+69% +$1.67K ﹤0.01% 3386
2016
Q2 		$1.99K Buy
+39
New +$6.04K ﹤0.01% 3450

Other funds holding LPCN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets's LPCN Position: Q4 2019 in Review

BNP Paribas Financial Markets held its Lipocine (LPCN) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4465.

BNP Paribas Financial Markets first reported a position in LPCN in Q2 2016 and has held it in 4 quarters since. The position peaked at $5.02K in Q3 2016. 32 funds tracked by Wall St. Rank hold LPCN as of Q4 2019.

  • BNP Paribas Financial Markets held 0 shares of Lipocine worth $0 as of Q4 2019.
  • BNP Paribas Financial Markets left its Lipocine share count unchanged in Q4 2019.
  • Lipocine made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q4 2019, its #4465 holding.
  • BNP Paribas Financial Markets first reported a position in Lipocine in Q2 2016 and has held it in 4 quarters since.
  • BNP Paribas Financial Markets's Lipocine position peaked at $5.02K in Q3 2016.
  • 32 funds tracked by Wall St. Rank held Lipocine as of Q4 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.